

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.26357375 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.26357375 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.26357375 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.26357375 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.26357375 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.26357375 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.36132789 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.36132789 |
| 9 | positive regulation of histone deacetylation (GO:0031065) | 4.35215320 |
| 10 | DNA deamination (GO:0045006) | 4.09796140 |
| 11 | cellular extravasation (GO:0045123) | 4.07703193 |
| 12 | N-acetylneuraminate metabolic process (GO:0006054) | 3.84553832 |
| 13 | microglial cell activation (GO:0001774) | 3.81793571 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 3.72530403 |
| 15 | positive regulation of protein deacetylation (GO:0090312) | 3.69158450 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.67443975 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67058263 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64726545 |
| 19 | tolerance induction (GO:0002507) | 3.64036831 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62593225 |
| 21 | negative regulation of phagocytosis (GO:0050765) | 3.61791794 |
| 22 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.53596797 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51376595 |
| 24 | response to host immune response (GO:0052572) | 3.51376595 |
| 25 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.50962900 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48095992 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 3.43573812 |
| 28 | base-excision repair, AP site formation (GO:0006285) | 3.42190101 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38977550 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34878029 |
| 31 | peptidyl-histidine modification (GO:0018202) | 3.29395372 |
| 32 | L-fucose catabolic process (GO:0042355) | 3.26632931 |
| 33 | fucose catabolic process (GO:0019317) | 3.26632931 |
| 34 | L-fucose metabolic process (GO:0042354) | 3.26632931 |
| 35 | response to interleukin-15 (GO:0070672) | 3.23898098 |
| 36 | neutrophil mediated immunity (GO:0002446) | 3.21188570 |
| 37 | leukocyte aggregation (GO:0070486) | 3.14166877 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14099676 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12909434 |
| 40 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.09971285 |
| 41 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07390047 |
| 42 | negative regulation of telomere maintenance (GO:0032205) | 3.07266732 |
| 43 | opioid receptor signaling pathway (GO:0038003) | 3.03408972 |
| 44 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01707753 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01023071 |
| 46 | response to host (GO:0075136) | 3.01023071 |
| 47 | response to host defenses (GO:0052200) | 3.01023071 |
| 48 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99072762 |
| 49 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.96313029 |
| 50 | regulation of growth of symbiont in host (GO:0044126) | 2.96313029 |
| 51 | negative regulation of growth of symbiont in host (GO:0044130) | 2.96313029 |
| 52 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.96313029 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 2.94908855 |
| 54 | regulation of chemokine biosynthetic process (GO:0045073) | 2.93865529 |
| 55 | neutrophil activation (GO:0042119) | 2.92863523 |
| 56 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.89918019 |
| 57 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.87522648 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 2.86813422 |
| 59 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.85909839 |
| 60 | mast cell activation (GO:0045576) | 2.81030782 |
| 61 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.80315359 |
| 62 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.79767623 |
| 63 | respiratory burst (GO:0045730) | 2.78356602 |
| 64 | positive regulation of defense response to virus by host (GO:0002230) | 2.77817915 |
| 65 | regulation of thymocyte apoptotic process (GO:0070243) | 2.74589412 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72935068 |
| 67 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.72842729 |
| 68 | positive regulation of interleukin-17 production (GO:0032740) | 2.71092001 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.69237414 |
| 70 | response to interferon-beta (GO:0035456) | 2.68182663 |
| 71 | response to type I interferon (GO:0034340) | 2.67700467 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.65997514 |
| 73 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.65855631 |
| 74 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65575321 |
| 75 | granulocyte activation (GO:0036230) | 2.65200220 |
| 76 | macrophage activation (GO:0042116) | 2.64013618 |
| 77 | cellular response to type I interferon (GO:0071357) | 2.61943462 |
| 78 | type I interferon signaling pathway (GO:0060337) | 2.61943462 |
| 79 | regulation of B cell apoptotic process (GO:0002902) | 2.61880406 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.61334372 |
| 81 | cellular ketone body metabolic process (GO:0046950) | 2.61046968 |
| 82 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.60957283 |
| 83 | negative T cell selection (GO:0043383) | 2.60705510 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.60322217 |
| 85 | amyloid precursor protein catabolic process (GO:0042987) | 2.60206423 |
| 86 | myeloid leukocyte mediated immunity (GO:0002444) | 2.60027394 |
| 87 | leukocyte degranulation (GO:0043299) | 2.59749923 |
| 88 | negative regulation of interleukin-1 production (GO:0032692) | 2.58532019 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.58147170 |
| 90 | germinal center formation (GO:0002467) | 2.55550698 |
| 91 | positive regulation of T cell apoptotic process (GO:0070234) | 2.55216066 |
| 92 | mast cell activation involved in immune response (GO:0002279) | 2.54751722 |
| 93 | mast cell degranulation (GO:0043303) | 2.54751722 |
| 94 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.54593051 |
| 95 | cellular response to interferon-beta (GO:0035458) | 2.54247867 |
| 96 | defense response to protozoan (GO:0042832) | 2.52095583 |
| 97 | regulation of memory T cell differentiation (GO:0043380) | 2.51550793 |
| 98 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.49520396 |
| 99 | cellular response to exogenous dsRNA (GO:0071360) | 2.48419470 |
| 100 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.48416013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.85119024 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05614285 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.05573798 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.81848628 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.65428156 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46350984 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44446934 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42174671 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37908056 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.37303478 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20555378 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15379639 |
| 13 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 2.10114017 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05468219 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.05178330 |
| 16 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98514504 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93881338 |
| 18 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93746092 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93029353 |
| 20 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.92319214 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91817663 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.90891707 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.90019456 |
| 24 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.85073006 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.80425125 |
| 26 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72377773 |
| 27 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.70673212 |
| 28 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.66790733 |
| 29 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.65032957 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63542578 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.62706696 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.60260240 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.60140052 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.58947781 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57269295 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54421418 |
| 37 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.53726226 |
| 38 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.51150087 |
| 39 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.50138253 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47579005 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.45855885 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.44537958 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44249573 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43743052 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43527394 |
| 46 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.43129863 |
| 47 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.42004342 |
| 48 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.41546445 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41383369 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38576488 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38423789 |
| 52 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.37451515 |
| 53 | ERA_21632823_ChIP-Seq_H3396_Human | 1.37397529 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37184346 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36970771 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.36848354 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36351613 |
| 58 | P300_27268052_Chip-Seq_Bcells_Human | 1.36222876 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34859600 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34506489 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.33958931 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30330186 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30057630 |
| 64 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29772366 |
| 65 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29115143 |
| 66 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.28301196 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.24342151 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20482264 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20455395 |
| 70 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.20336297 |
| 71 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20187464 |
| 72 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19518194 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19359381 |
| 74 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.18182442 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.17927275 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17419185 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17315094 |
| 78 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16589958 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14411654 |
| 80 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.13271258 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12409145 |
| 82 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11919504 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11856443 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10396054 |
| 85 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10368129 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09873219 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08754461 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07604725 |
| 89 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.07217510 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05321093 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03640166 |
| 92 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02713752 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01132289 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00345799 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99503490 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98732724 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98117892 |
| 98 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95875589 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95819662 |
| 100 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95395146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.52960445 |
| 2 | MP0003436_decreased_susceptibility_to | 3.25138072 |
| 3 | MP0001790_abnormal_immune_system | 2.87544919 |
| 4 | MP0005387_immune_system_phenotype | 2.87544919 |
| 5 | MP0005083_abnormal_biliary_tract | 2.81866488 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.80923124 |
| 7 | MP0005671_abnormal_response_to | 2.70184200 |
| 8 | MP0001800_abnormal_humoral_immune | 2.58597986 |
| 9 | MP0009785_altered_susceptibility_to | 2.57881821 |
| 10 | MP0000685_abnormal_immune_system | 2.51207548 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.46351243 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.40178540 |
| 13 | MP0002277_abnormal_respiratory_mucosa | 2.36950913 |
| 14 | MP0002723_abnormal_immune_serum | 2.32195065 |
| 15 | MP0005025_abnormal_response_to | 2.26470135 |
| 16 | MP0002419_abnormal_innate_immunity | 2.25784086 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.14618966 |
| 18 | MP0005310_abnormal_salivary_gland | 2.13220725 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.12318016 |
| 20 | MP0001819_abnormal_immune_cell | 2.11803816 |
| 21 | MP0001986_abnormal_taste_sensitivity | 2.03648768 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.99547136 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98943081 |
| 24 | MP0001873_stomach_inflammation | 1.97014668 |
| 25 | MP0002254_reproductive_system_inflammat | 1.82080287 |
| 26 | MP0002405_respiratory_system_inflammati | 1.76925033 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.74723985 |
| 28 | MP0003646_muscle_fatigue | 1.74674677 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.72300137 |
| 30 | MP0009764_decreased_sensitivity_to | 1.65733216 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.64998463 |
| 32 | MP0003195_calcinosis | 1.63792384 |
| 33 | MP0003303_peritoneal_inflammation | 1.60573659 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.57826864 |
| 35 | MP0005451_abnormal_body_composition | 1.56804900 |
| 36 | MP0005365_abnormal_bile_salt | 1.53510007 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.52935332 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.50414493 |
| 39 | MP0008872_abnormal_physiological_respon | 1.47976978 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.47829296 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.47685855 |
| 42 | MP0000716_abnormal_immune_system | 1.46041064 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.45927897 |
| 44 | MP0006082_CNS_inflammation | 1.45673474 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.43647277 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.40019692 |
| 47 | MP0003866_abnormal_defecation | 1.34879215 |
| 48 | MP0002398_abnormal_bone_marrow | 1.34166454 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.33024962 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.31506704 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.28468495 |
| 52 | MP0001529_abnormal_vocalization | 1.23142728 |
| 53 | MP0002722_abnormal_immune_system | 1.21854424 |
| 54 | MP0003252_abnormal_bile_duct | 1.21681062 |
| 55 | MP0008469_abnormal_protein_level | 1.19300777 |
| 56 | MP0008260_abnormal_autophagy | 1.17818716 |
| 57 | MP0002736_abnormal_nociception_after | 1.15112040 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.13276225 |
| 59 | MP0004381_abnormal_hair_follicle | 1.10436236 |
| 60 | MP0002429_abnormal_blood_cell | 1.07483908 |
| 61 | MP0003045_fibrosis | 1.07255100 |
| 62 | MP0004947_skin_inflammation | 1.06095189 |
| 63 | MP0001919_abnormal_reproductive_system | 1.03347339 |
| 64 | MP0000703_abnormal_thymus_morphology | 0.98371976 |
| 65 | MP0002928_abnormal_bile_duct | 0.92073347 |
| 66 | MP0002933_joint_inflammation | 0.91018210 |
| 67 | MP0001764_abnormal_homeostasis | 0.90807238 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.87705544 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.87571678 |
| 70 | MP0002693_abnormal_pancreas_physiology | 0.87262597 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.86460116 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 0.85014903 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.83902492 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.83240508 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.82801318 |
| 76 | MP0002132_abnormal_respiratory_system | 0.82223504 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.81883827 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.81720452 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.79958528 |
| 80 | MP0002163_abnormal_gland_morphology | 0.79549798 |
| 81 | MP0004142_abnormal_muscle_tone | 0.76223798 |
| 82 | MP0008058_abnormal_DNA_repair | 0.75881167 |
| 83 | MP0001663_abnormal_digestive_system | 0.74965228 |
| 84 | MP0005266_abnormal_metabolism | 0.73962316 |
| 85 | MP0008874_decreased_physiological_sensi | 0.72600840 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.72528468 |
| 87 | MP0002822_catalepsy | 0.69889087 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.68200266 |
| 89 | MP0004043_abnormal_pH_regulation | 0.67581510 |
| 90 | MP0010329_abnormal_lipoprotein_level | 0.67407113 |
| 91 | MP0004133_heterotaxia | 0.66905610 |
| 92 | MP0000427_abnormal_hair_cycle | 0.65931170 |
| 93 | MP0005670_abnormal_white_adipose | 0.65779040 |
| 94 | MP0003075_altered_response_to | 0.64827655 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.63885098 |
| 96 | MP0003786_premature_aging | 0.63692084 |
| 97 | MP0009745_abnormal_behavioral_response | 0.60057568 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.57811041 |
| 99 | MP0003787_abnormal_imprinting | 0.57118438 |
| 100 | MP0001270_distended_abdomen | 0.56533638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.21082989 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.10060223 |
| 3 | Stomatitis (HP:0010280) | 4.02952263 |
| 4 | Optic neuritis (HP:0100653) | 3.84353204 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 3.84353204 |
| 6 | Orchitis (HP:0100796) | 3.73843491 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71627152 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.65128330 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.53574139 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.37128562 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.37128562 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29605984 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.26961809 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.22540868 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.10066771 |
| 16 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.09915831 |
| 17 | Recurrent skin infections (HP:0001581) | 3.09843726 |
| 18 | Progressive microcephaly (HP:0000253) | 3.06809694 |
| 19 | Tetany (HP:0001281) | 3.05631451 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.03145367 |
| 21 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.01125758 |
| 22 | Eczematoid dermatitis (HP:0000976) | 2.89404413 |
| 23 | Encephalitis (HP:0002383) | 2.85191560 |
| 24 | Clumsiness (HP:0002312) | 2.84934598 |
| 25 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.84123287 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 2.76892904 |
| 27 | Cheilitis (HP:0100825) | 2.72207824 |
| 28 | Visual hallucinations (HP:0002367) | 2.70821484 |
| 29 | Abnormality of T cell physiology (HP:0011840) | 2.69072755 |
| 30 | Tubular atrophy (HP:0000092) | 2.68391871 |
| 31 | Pustule (HP:0200039) | 2.65143508 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.60470913 |
| 33 | Hypochromic anemia (HP:0001931) | 2.55714798 |
| 34 | Hemoptysis (HP:0002105) | 2.53112668 |
| 35 | Pendular nystagmus (HP:0012043) | 2.51232109 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.50497796 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 2.47476186 |
| 38 | Episodic fever (HP:0001954) | 2.43244101 |
| 39 | Meningitis (HP:0001287) | 2.42125671 |
| 40 | Attenuation of retinal blood vessels (HP:0007843) | 2.39347608 |
| 41 | IgG deficiency (HP:0004315) | 2.29447128 |
| 42 | Vasculitis (HP:0002633) | 2.29441844 |
| 43 | Anorexia (HP:0002039) | 2.26254857 |
| 44 | Parakeratosis (HP:0001036) | 2.26224113 |
| 45 | Stomach cancer (HP:0012126) | 2.25600486 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.22980759 |
| 47 | Nephronophthisis (HP:0000090) | 2.22618915 |
| 48 | Concave nail (HP:0001598) | 2.19260547 |
| 49 | Abnormality of T cells (HP:0002843) | 2.18150254 |
| 50 | Obstructive lung disease (HP:0006536) | 2.16843740 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16843740 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13360215 |
| 53 | Chest pain (HP:0100749) | 2.13337392 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.13136204 |
| 55 | Inability to walk (HP:0002540) | 2.12686967 |
| 56 | Severe visual impairment (HP:0001141) | 2.12300317 |
| 57 | Polydipsia (HP:0001959) | 2.11488369 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.11488369 |
| 59 | Progressive inability to walk (HP:0002505) | 2.06247238 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.06170044 |
| 61 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05154716 |
| 62 | 3-Methylglutaconic aciduria (HP:0003535) | 2.04393573 |
| 63 | Prostate neoplasm (HP:0100787) | 2.03682905 |
| 64 | Pancreatic cysts (HP:0001737) | 2.01701445 |
| 65 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01598847 |
| 66 | Opisthotonus (HP:0002179) | 1.99003165 |
| 67 | Hyperventilation (HP:0002883) | 1.98988070 |
| 68 | Increased IgM level (HP:0003496) | 1.96183338 |
| 69 | Type II lissencephaly (HP:0007260) | 1.96034782 |
| 70 | Lissencephaly (HP:0001339) | 1.94251230 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 1.92719743 |
| 72 | Abnormality of the pleura (HP:0002103) | 1.92368985 |
| 73 | Severe muscular hypotonia (HP:0006829) | 1.90934099 |
| 74 | Petechiae (HP:0000967) | 1.88496082 |
| 75 | Keratitis (HP:0000491) | 1.88398672 |
| 76 | Acute hepatic failure (HP:0006554) | 1.88299110 |
| 77 | Microretrognathia (HP:0000308) | 1.88080447 |
| 78 | Hypoplasia of the uterus (HP:0000013) | 1.87887281 |
| 79 | Abnormality of the renal medulla (HP:0100957) | 1.85247524 |
| 80 | Abnormality of the prostate (HP:0008775) | 1.84340991 |
| 81 | Decreased central vision (HP:0007663) | 1.83883007 |
| 82 | Ketosis (HP:0001946) | 1.82986550 |
| 83 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82254979 |
| 84 | Gangrene (HP:0100758) | 1.81653361 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 1.80411125 |
| 86 | Hypothermia (HP:0002045) | 1.78861271 |
| 87 | Ketoacidosis (HP:0001993) | 1.78164947 |
| 88 | Amelogenesis imperfecta (HP:0000705) | 1.76251127 |
| 89 | Abnormality of the endocardium (HP:0004306) | 1.76232864 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.76038575 |
| 91 | Chronic otitis media (HP:0000389) | 1.75576934 |
| 92 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73443382 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72321204 |
| 94 | Cerebellar dysplasia (HP:0007033) | 1.72191354 |
| 95 | Polyuria (HP:0000103) | 1.70482073 |
| 96 | Intellectual disability, progressive (HP:0006887) | 1.69322486 |
| 97 | Premature loss of primary teeth (HP:0006323) | 1.68565228 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 1.68368212 |
| 99 | Brushfield spots (HP:0001088) | 1.66599404 |
| 100 | Increased CSF lactate (HP:0002490) | 1.64948540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.59781884 |
| 2 | PINK1 | 3.49563276 |
| 3 | RIPK4 | 2.98130154 |
| 4 | TNK2 | 2.85916871 |
| 5 | IRAK4 | 2.46935099 |
| 6 | ERN1 | 2.34837674 |
| 7 | TAOK1 | 2.26248996 |
| 8 | BCKDK | 2.23946327 |
| 9 | TLK1 | 2.23686082 |
| 10 | FRK | 2.22018446 |
| 11 | TXK | 2.11941731 |
| 12 | ADRBK2 | 2.07753168 |
| 13 | CAMKK2 | 2.00437945 |
| 14 | EPHB1 | 1.99568301 |
| 15 | SMG1 | 1.96884165 |
| 16 | NUAK1 | 1.83366087 |
| 17 | CCNB1 | 1.74918138 |
| 18 | BLK | 1.69036542 |
| 19 | IKBKE | 1.65031675 |
| 20 | MAP3K11 | 1.63999127 |
| 21 | GRK6 | 1.61449133 |
| 22 | VRK2 | 1.56988307 |
| 23 | TAF1 | 1.53078509 |
| 24 | MUSK | 1.50952837 |
| 25 | TESK2 | 1.50942408 |
| 26 | WNK4 | 1.45406795 |
| 27 | ZAP70 | 1.45179623 |
| 28 | IKBKB | 1.42939870 |
| 29 | SYK | 1.42623494 |
| 30 | JAK3 | 1.41368585 |
| 31 | SIK3 | 1.36963868 |
| 32 | NEK2 | 1.35854356 |
| 33 | CSK | 1.30589245 |
| 34 | FES | 1.28441790 |
| 35 | TYK2 | 1.27485894 |
| 36 | MAP2K3 | 1.26652751 |
| 37 | CHUK | 1.14440530 |
| 38 | ZAK | 1.10080513 |
| 39 | BTK | 1.06832245 |
| 40 | INSRR | 1.06489108 |
| 41 | PRKCQ | 1.06449379 |
| 42 | PRKD2 | 1.04409109 |
| 43 | MAP4K2 | 1.01736231 |
| 44 | CSF1R | 0.97283373 |
| 45 | DAPK2 | 0.97085120 |
| 46 | MAP3K6 | 0.94032142 |
| 47 | MAP2K6 | 0.93521070 |
| 48 | HCK | 0.92364834 |
| 49 | LYN | 0.89163918 |
| 50 | IRAK3 | 0.87553406 |
| 51 | MAPKAPK3 | 0.86339675 |
| 52 | GRK1 | 0.86141709 |
| 53 | HIPK2 | 0.82954711 |
| 54 | FGR | 0.82367345 |
| 55 | WNK3 | 0.81318835 |
| 56 | ITK | 0.81020087 |
| 57 | LCK | 0.80816478 |
| 58 | MAP2K2 | 0.79252054 |
| 59 | ACVR1B | 0.77518591 |
| 60 | PRKCI | 0.76777486 |
| 61 | CAMKK1 | 0.76390731 |
| 62 | PHKG1 | 0.74185024 |
| 63 | PHKG2 | 0.74185024 |
| 64 | MAPK13 | 0.74085378 |
| 65 | TBK1 | 0.72083315 |
| 66 | CSNK1G3 | 0.70108047 |
| 67 | MAP3K7 | 0.69990339 |
| 68 | TRIM28 | 0.67873484 |
| 69 | IRAK1 | 0.66019526 |
| 70 | MARK3 | 0.63731446 |
| 71 | MAP3K14 | 0.61814379 |
| 72 | PRKAA2 | 0.61447717 |
| 73 | MAP3K3 | 0.61310150 |
| 74 | TAOK2 | 0.61038724 |
| 75 | NME1 | 0.58279535 |
| 76 | STK11 | 0.56552225 |
| 77 | LRRK2 | 0.56312897 |
| 78 | CSNK1G2 | 0.54106521 |
| 79 | TRIB3 | 0.52665538 |
| 80 | PTK2B | 0.52593775 |
| 81 | MARK2 | 0.51669771 |
| 82 | PRKCZ | 0.49403431 |
| 83 | PRKG2 | 0.49306754 |
| 84 | RPS6KA6 | 0.48848499 |
| 85 | CAMK1D | 0.45164801 |
| 86 | TAOK3 | 0.43997397 |
| 87 | ADRBK1 | 0.43700110 |
| 88 | MAP2K4 | 0.43136754 |
| 89 | CAMK1 | 0.41687942 |
| 90 | PRKD3 | 0.41161748 |
| 91 | TEC | 0.40093615 |
| 92 | MATK | 0.38854204 |
| 93 | RPS6KA4 | 0.38480497 |
| 94 | MAP2K7 | 0.38317266 |
| 95 | JAK2 | 0.38113895 |
| 96 | CSNK1A1L | 0.37762157 |
| 97 | DAPK1 | 0.37561041 |
| 98 | PASK | 0.37093491 |
| 99 | KIT | 0.36725069 |
| 100 | DYRK2 | 0.35291655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82085345 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.68100446 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64044772 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.32762249 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.24332940 |
| 6 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.23788702 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99882009 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98932094 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89752310 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.84785546 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79195809 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72768496 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 1.68970249 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66233348 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65421396 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.63012186 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62913581 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62565180 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61178483 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.59380228 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.55779028 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55745483 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54977603 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51051241 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.48421716 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45836297 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45332836 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44228259 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44181059 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39789623 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39686577 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37615129 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31926466 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30011996 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28289850 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28130365 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27413230 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.26013319 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25323308 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20879823 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17946243 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16100063 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16065332 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13511556 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13398923 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 1.13125481 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12216977 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12181870 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.11987254 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11276632 |
| 51 | Asthma_Homo sapiens_hsa05310 | 1.11075349 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07461190 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04100370 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03298600 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03032037 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.01668566 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.01632768 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00903364 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99382159 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.96468994 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96175384 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.94606913 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94312403 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90539831 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.88853556 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.83736788 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83584859 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80408765 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77974269 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76778875 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.75867204 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72900444 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70616940 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70558434 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.69391294 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68940948 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68738575 |
| 78 | RNA polymerase_Homo sapiens_hsa03020 | 0.62702684 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.57669676 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56130658 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55024901 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53431662 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51881623 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48474735 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.48201786 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45821078 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44704555 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42764605 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40586592 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40460702 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.39807905 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.39692469 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39444327 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37383374 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37133015 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.36693232 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.35311669 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33285444 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32268924 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.31677998 |

